Navigation Links
Jazz Pharmaceuticals Announces Participation In Three Investor Conferences In November
Date:11/9/2012

#160;
  • Piper Jaffray 24th Annual Healthcare Conference in New York, NY on Wednesday, November 28, 2012 at 10:00 a.m. EST/3:00 p.m. GMT. Kate Falberg, executive vice president and chief financial officer, will provide a business update.
  • An archived version of each webcast will be available for at least one week following each respective presentation on the Investors section of the company's website at www.jazzpharmaceuticals.com.

    About Jazz Pharmaceuticals
    Jazz Pharmaceuticals plc is a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing and commercializing innovative products that address unmet medical needs. The company has a diverse portfolio of products in the areas of narcolepsy, oncology, pain and psychiatry. The company's U.S. marketed products in these areas include: Xyrem® (sodium oxybate) oral solution, Erwinaze® (asparaginase Erwinia chrysanthemi), Prialt® (ziconotide) intrathecal infusion, Luvox CR® (fluvoxamine maleate), FazaClo® (clozapine, USP) HD and FazaClo LD. Outside of the U.S., Jazz Pharmaceuticals also has a number of products marketed by its international division, EUSA Pharma.


    '/>"/>
    SOURCE Jazz Pharmaceuticals plc
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2

    Related medicine technology :

    1. Achillion Pharmaceuticals, Inc. Hosts the HCV Connection Media Briefing at the 63rd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
    2. Omthera Pharmaceuticals Presents Data From Analysis Of EVOLVE Trial Showing That Epanova Lowers ApoC-III, A Key Predictor of Cardiovascular Risk
    3. Jazz Pharmaceuticals Announces Third Quarter 2012 Results
    4. Harwood Feffer LLP Announces Investigation of DUSA Pharmaceuticals, Inc.
    5. Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
    6. Isis Pharmaceuticals To Present At The 2012 Credit Suisse Healthcare Conference
    7. Savient Pharmaceuticals Reports Third Quarter 2012 Financial Results
    8. Genoa Pharmaceuticals announces $1.2M Financing
    9. Inovio Pharmaceuticals Reports 2012 Third Quarter Financial Results
    10. Arisaph Pharmaceuticals Reports Positive Results From Two Safety Clinical Trials For Its Niacin Analog (ARI-3037MO)
    11. Oramed Pharmaceuticals to Present at the 12th Annual Diabetes Technology Society Meeting in Bethesda, MD, Nov 8-10, 2012
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/27/2015)... YORK , March 27, 2015 Object ... the blind, visually impaired and elderly. The VelaSense ... these individuals to lead more independent, productive and fulfilling ... Technology which will allow users to identify objects from ... as well as create customized object databases for personal ...
    (Date:3/27/2015)... AUGUSTA, Ga. , March 27, 2015  Holographic ... innovator in the field of holographic medical imaging, is ... of its Kickstarter campaign. Launching on April 20 th ... Voxbox and Voxbox Pro. The 8-inch and 22-inch displays ... at home for the first time. In addition to ...
    (Date:3/27/2015)... , March 27, 2015   Cypher ... today announced new data showing that, compared to ... technology provided highly equivalent interpretations of whether ... and did so in a fraction of the ... way for more comprehensive genetic analysis in non-invasive ...
    Breaking Medicine Technology:VelaSense Object Recognition Technology for the Blind was unveiled at Baruch College's CCVIP 8th Annual Conference 2Holographic Optical Technologies brings cutting-edge holograms to consumer market through upcoming Kickstarter campaign 2Holographic Optical Technologies brings cutting-edge holograms to consumer market through upcoming Kickstarter campaign 3New Data at ACMG Shows Cypher's Software Can Automate Interpretation of Genetic Variants to Advance Non-invasive Prenatal Testing 2New Data at ACMG Shows Cypher's Software Can Automate Interpretation of Genetic Variants to Advance Non-invasive Prenatal Testing 3
    ... 31, 2011 Polaris Group (Polaris) today announced that ... the company,s Special Protocol Assessment (SPA) for a Phase ... in patients with advanced hepatocellular carcinoma (HCC). The randomized, ... have failed prior systemic chemotherapy. The primary endpoint of ...
    ... 2011 Amarin Corporation plc (Nasdaq: AMRN ... cardiovascular disease, today announced that Executive Chairman and Chief ... EDT on April, 6, 2011 at the 10th Annual ... President, John Thero, will be available at the conference ...
    Cached Medicine Technology:FDA Approves Special Protocol Assessment for Phase 3 Trial of Polaris Group's Cancer Therapeutic, ADI-PEG 20, in the Treatment of Hepatocellular Carcinoma 2FDA Approves Special Protocol Assessment for Phase 3 Trial of Polaris Group's Cancer Therapeutic, ADI-PEG 20, in the Treatment of Hepatocellular Carcinoma 3Amarin to Present at the 10th Annual Needham Healthcare Conference 2
    (Date:3/28/2015)... The California-based leading wig brand UniWigs has ... on UniWigs during the Easter Holidays from today until ... on April Fools’ Day. , As the winter fades ... corner. Easter Festival, with religious origins to countries in ... after Christmas. The best wig provider, UniWigs, would like ...
    (Date:3/28/2015)... New York, NY (PRWEB) March 28, 2015 ... 2015 highlighted a problem which could prove critical to ... Why system testing, a critical aspect of data security, ... payment card industry data security report, every major category ... vulnerability scanning and penetration testing. “With all the craziness ...
    (Date:3/28/2015)... Las Vegas, NV (PRWEB) March 28, 2015 ... surgery experiences re-injury, according to research presented today at ... ) Specialty Day. The study examined the long term ... younger. , “We examined survey data from 242 ... noted lead author Justin P. Roe, MBBS, FRACS, from ...
    (Date:3/28/2015)... 28, 2015 Early surgery may not ... V AC joint injuries, according to new research from ... the American Orthopaedic Society for Sports Medicine’s ( AOSSM ... faster when surgery was not performed. , The final ... surgical treatment and 17 receiving non-surgical therapy. Of the ...
    (Date:3/28/2015)... OR (PRWEB) March 28, 2015 Lately ... the media regarding recent changes and proposals around the ... , current and former collegiate student-athletes across a spectrum ... and reflect on common challenges. The special panel consists ... country in sports ranging from football, track and field, ...
    Breaking Medicine News(10 mins):Health News:UniWigs Is Sending Out Mysterious Gifts During the Easter Holidays 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 3Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 4Health News:Young Athletes at Greater Risk for Re-Injury after ACL Surgery 2Health News:For Type V AC Joint Injuries, Early Surgery May Not Be the Best Approach 2Health News:SCI TV Panel of Former College Athletes Discusses Student Athlete Experience 2Health News:SCI TV Panel of Former College Athletes Discusses Student Athlete Experience 3
    ... 14 (HealthDay News) -- Watching this year,s NCAA March Madness ... bet on the games, one expert suggests. Though the ... message boards seems to suggest that predicting the outcome of ... M. Nowlis, a marketing professor at the Olin Business School ...
    ... Department of Energy,s (DOE) Brookhaven National Laboratory, Stony Brook ... "wearable," portable PET scanner they,ve developed for rats. The ... studying brain function and behavior in fully awake, moving ... studies in the April 2011 issue of Nature Methods. ...
    ... , FRIDAY, March 11 (HealthDay News) -- Forget that ... in romantic relationships. Those who are unrealistically idealistic ... than the realists, new research contends. The idealization ... that strikes marriages over time, said study author Dr. ...
    ... invasive breast cancer in the same breast are at ... who do not develop invasive disease, according to a ... of the National Cancer Institute. Retrospective studies ... (lumpectomy) to mastectomy and found that survival rates are ...
    ... News) -- A doctor,s empathy can improve the care of ... being a good doctor, according to a new study. ... and June 2009 by 29 doctors at Thomas Jefferson University ... empathy for patients, while the quality of patient care was ...
    ... UC Irvine,s Dr. Bang H. Hoang and colleagues have ... for their work advancing the understanding of how bone cancer ... was announced at the recent American Academy of Orthopaedic Surgeons ... the most prestigious honors bestowed by the AAOS and the ...
    Cached Medicine News:Health News:Miniature 'wearable' PET scanner ready for use 2Health News:Miniature 'wearable' PET scanner ready for use 3Health News:Miniature 'wearable' PET scanner ready for use 4Health News:Think You Have a Perfect Partner? That's a Good Sign 2Health News:Think You Have a Perfect Partner? That's a Good Sign 3Health News:DCIS patients who get invasive breast cancer have higher mortality 2
    ... Neuroprene™ soft supports are a ... to proprioceptive taping for common orthopedic ... help provide specific compression and lateral ... receptors (proprioceptors) in the skin and ...
    ... The C.Ti.2 Hockey is a lightweight, ... meet the unique requirements of hockey,players. Tested ... a new, streamlined frame shape that is ... (VMO). Plus, the upper and lower lateral ...
    ... Adjustable Patella Donut is a neoprene ... core and polyester Lycra Fabric that ... full-circumference donut provides for patellar control. ... based allergies or irritations. Click here ...
    The Deluxe Knee Immobilizer provides superb lightweight immobilization following injury or surgery. It is available in a wide array of sizes for excellent comfort and fit....
    Medicine Products: